Upcoming Events

  1. PCT Amsterdam
  2. OC17

    9th Global OpenClinica Congress 2017

    December 4 - December 5

Register Today!

Get Free Test Access


News 2017-09-18T12:46:59+00:00

Cyntegrity’s CEO Presents at MCC: Process Innovation in Clinical Trial Monitoring

November 16, 2017|0 Comments

Dr. Artem Andrianov, the Cyntegrity's CEO, will be presenting on the recent publication in Applied Clinical Trials at MCC's next meeting on 11-Dec-2017 at 10am EST. Registration link below. The link to the peer-reviewed [...]


Article at ACT: “Process Innovation in Clinical Trial Monitoring”

August 23, 2017|0 Comments

Cyntegrity employees were happy to contribute to the new peer reviewed article in Applied Clinical Trials: "The PUEKS Project: Process Innovation in Clinical Trial Monitoring" http://www.appliedclinicaltrialsonline.com/pueks-project-process-innovation-clinical-trial-monitoring


ICH GCP Addendum E6 R2 comes into operation!

June 14, 2017|0 Comments

Today the ICH GCP Addendum E6 R2 comes into operation. Therefore, we summarized the useful resources for your kind perusal: GCP E6 R2 Addendum itself - http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Step_4.pdf PDF Mindmap of all GCP E6 R2 [...]


Press Release: Cyntegrity partners with Sollers Institute

May 9, 2017|0 Comments

25.04.2016. Cyntegrity, cloud solution provider for the efficient Risk-based Monitoring (RBM), is pleased to announce its partnership with Sollers Institute (New Jersey, US). Sollers is the leader in training related to the clinical research, [...]


ICH Finalized GCP Addendum E6 Revision 2

November 18, 2016|0 Comments

The ICH GCP Addendum E6 R(2) is final now! Global good clinical practice (GCP) guideline amendment adopted The 1996 ICH guideline on GCP is one of the most significant achievements of the ICH process, [...]


WHO Guideline on Good Data and Record Management Practices is Final

November 9, 2016|0 Comments

The WHO guideline on Good Data and Record Management practices is now final, below you find the link. Particularly interesting is that this guideline talks about quality risk management: Quality risk management and sound scientific [...]


Andy Lawton, a leader in TransCelerate’s RBM initiative joins Cyntegrity

September 22, 2016|0 Comments

Andy Lawton, a top expert with 35+ years of experience in clinical trials in the areas of biometrics, data management programming, system development, computer system validation and risk-based approach, joins Cyntegrity as RBM Advisory Board [...]


A new RBM Sandbox is Released (Ver. 4.0)

August 9, 2016|0 Comments

Do you want to try RBM on practice? Still confused by many offers and companies? Do you want to decide yourself based on objective evidence? Apply and test our newest RBM demo environment. Explore the [...]


Press Release: EarlyBird Flies to New Heights

July 1, 2016|0 Comments

01.07.2016. Cyntegrity, cloud solution service provider for the efficient Risk-based Monitoring (RBM) for clinical trials, is pleased to announce a release of the newest version of its holistic RBM platform EarlyBird 4.0. The latest EarlyBird [...]


Press Release: Synergy and Cyntegrity announce partnership to foster RBM practicality

June 22, 2016|0 Comments

21.06.2016. Synergy, Russian fastest Contract Research Organization (CRO) and Cyntegrity, a German technology provider for efficient Risk-based Monitoring (RBM), are pleased to announce a partnership, in order to foster the practicality of RBM. Nowadays, the [...]


Johann Proeve, Ph.D., strengthens Cyntegrity as CSO

May 24, 2016|0 Comments

J. Proeve, Ph.D., an expert with 35+ years of experience as Global Data Management Head at Bayer started this week as Chief Scientific Officer at Cyntegrity. He takes the responsibility of building up a proper Risk-based Monitoring (RBM) strategy [...]


Data from Global RACT Analysis Reveals Subjectivity

May 11, 2016|0 Comments

What are the most common risks in clinical trials? What challenges faces TransCelerate RACT? Read the answers in the latest article published on ACT. by Moe Alsumidaie, Beat Widler, PhD, Peter Schiemann, PhD, Artem Andrianov, PhD Do [...]